SIGMA LABORATORIES LTD. (INDIA)🇸🇬 Health Sciences Authority
Approval Date
Mar 20, 2017
Approval ID
8d550a4388e6c326
Company
SIGMA LABORATORIES LTD. (INDIA)
Type
Therapeutic
Approval Details
Approval Id
8d550a4388e6c326
Drug Name
NAUSICALM TABLET 50MG
Product Name
NAUSICALM TABLET 50MG
Approval Number
SIN15193P
Approval Date
2017-03-20
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Dosage
<p><u><strong>Dosage and Administration</strong></u><br>
<em>For the Treatment of nausea induced by radiotherapy:</em><br>
<u>Adults and children over 12 Years:</u> One tablet every 6 to 8 hours, as required with a little water (up to a maximum of 3 tablets in 24 hours)<br>
<u>Use in the Elderly:</u> There have been no specific studies of cyclizine in the elderly. Experience has indicated that normal adult dosage is appropriate.</p>
<p><em>For the Prevention of Travel Sickness:</em><br>
<u>Adults and children over 12 Years:</u> One tablet every 6 to 8 hours (up to a maximum of 3 tablets in 24 hours), as required with a little water, first taken 1–2 hours before departure.<br>
The score line only serves to facilitate breaking for ease of swallowing and does not divide the tablet into equal half-doses.</p>
<p><u><strong>This product should not be used for more than 48 hours at a time</strong></u></p>
Route Of Administration
ORAL
Indication Info
<p><u><strong>Indications</strong></u><br>
Nausicalm is indicated for the prevention and treatment of nausea and vomiting associated with motion sickness and radiotherapy.</p>
Contraindications
<p><u><strong>Contraindications</strong></u><br>
Nausicalm should not be given to individuals with known hypersensitivity to cyclizine or in individuals with severe heart failure.</p>
